The Australian MRI-Linac technology at the Ingham Institute is one of only three in the world. It is an Australian-first initiative where radiation and imaging of tumours is done both in real-time, more effectively targeting radiation towards the tumour. The unique design of the system gives Ingham Institute cancer researchers the ability to position the treatment or radiation beam in two different arrangements which has not been possible before. This will allow our researchers to investigate the best way of using this machine to ensure the effectiveness of treatment, offering greater potential of improving patient treatment methods across a broad range of cancers.
The Centre for Circulating Tumour Cell Diagnostics and Research (CCDR) is a CONCERT supported initiative. The CCDR is located at the Ingham Institute next to the Liverpool Hospital (Sydney) and is unique in its approach towards precision oncology for cancer patients. The ability to non-invasively monitor cancer is an unprecedented breakthrough. Analysis of blood samples at the CCDR provides measurement of the presence, load and genetic makeup of tumour cells in a cancer patient. This capability ultimately aims to inform the clinician so individual therapies can be tailored for a given patient.